Approval

Approval  ·  Weekly Digest - 22 November to 28 November 2025
U.S. FDA approves PADCEV plus Keytruda for certain patients with bladder cancer

Weekly Digest – November 2025 Weekly Digest – November 2025 25 November 2025: U.S. FDA approves PADCEV plus Keytruda for certain patients with bladder cancer  The FDA has approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda as the first perioperative regimen to […]

by Sandhya Ramalingam

Continue Reading
Approval  ·  Weekly Digest - 22 November to 28 November 2025
Blenrep approved in Australia for use in adults with relapsed or refractory multiple myeloma as part of triplet combination therapy

Weekly Digest – November 2025 Weekly Digest – November 2025 24 November 2025: Blenrep approved in Australia for use in adults with relapsed or refractory multiple myeloma as part of triplet combination therapy Australia has approved Blenrep (belantamab mafodotin), a first-of-its-kind […]

by Sandhya Ramalingam

Continue Reading